Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
Adaptimmune Therapeutics () last released its quarterly earnings results on Tuesday, November 8th.
Finally, Mizuho upgraded shares of Adaptimmune Therapeutics from a “neutral” rating to a “buy” rating and set a $9.00 target price for the company in a report on Wednesday, November 9th.